Notox Bioscience, Inc. entered into a share exchange agreement to acquire Tropic International, Inc. (OTCPK:TRPO) in a reverse merger transaction on June 6, 2016. The transaction is structured as the purchase by Tropic International of all the issued and outstanding capital of Notox Bioscience in exchange for 100 million restricted shares of the Tropic International. The agreement includes a covenant that Tropic International will complete a 1:2 reverse split within 90 days of the closing date. Upon the completion of the transaction Tropic International will have approximately 56 million issued and outstanding shares of common stock, out of which 50 million will be held by Notox Bioscience shareholders. The transaction is subject to receipt of third party consents and satisfactory completion of due diligence investigation by Tropic International. John Marmora resigned as the Chief Executive Officer of Tropic and the sole officer and director of Notox, Zoran Konevic, was appointed to lead Tropic as the company's new Chief Executive Officre and to oversee the marketing of Notox throughout the world. Konevic has the experience and knowledge needed to lead Tropic. Konevic has also been appointed as a director of Tropic. Pursuant to a covenant in the share exchange agreement and as part of a minor restructuring, Tropic now plans to proceed with a 1:2 reverse split that is expected to be completed by mid-July, 2016.